Nexxa.ai | $4,400,000 | (Jul 22, 2025)
Litero AI | $800,000 | (Jul 22, 2025)
xLight Inc. | $40,000,000 | (Jul 22, 2025)
Certified by Founder
Lodge
RheumaGen
start up
United States
- Denver, Colorado
- 10/01/2025
- Series A
- $15,000,000
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado. For more information, please visit rheumagen.com.
- Industry Biotechnology Research
- Website https://www.rheumagen.com/
- LinkedIn https://www.linkedin.com/company/rheumagen/
Radical AI | $55,000,000 | (Jul 22, 2025)
LeadStory | $2,750,000 | (Jul 22, 2025)
Xelix | $160,000,000 | (Jul 22, 2025)
Toduba | $4,090,457 | (Jul 22, 2025)
Alix | $20,000,000 | (Jul 22, 2025)
Ovasave | $1,200,000 | (Jul 22, 2025)
Magentic | $5,500,000 | (Jul 22, 2025)
WattCarbon | Undisclosed Amount | (Jul 18, 2025)
Occupi | $3,000,000 | (Jul 18, 2025)